Drug Store News - Odyssey launches generic Urecholine
Odyssey Pharmaceuticals is marketing 5 mg, 10 mg and 50 mg tablets of bethanechol, the generic version of Merck’s Urecholine. The drug treats bladder obstructions. Three other Merck products: hypertension drug Vasotec (enalapril maleate), Pepcid (famotidine) for ulcers and Mevacor (lovastatin) for cholesterol likely will lose patent protection this year and next.
Related Results
FDA unleashes 16 generics of VasotecMerck gets good news on VasotecWatson’s generic Vasotec gets OKENALAPRIL.(Vasotec from Merck)(Company Business and Marketing)(Brief Article)Biovail Corp. (Active Pharmaceutical Ingredient Watch).(purchase of Vasotec,…
Teva received tentative approval for 20 and 40 mg famotidine tablets in October 1998. Pepcid’s patent expires this month.
COPYRIGHT 2001 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning
